| Commodity | Reporter | Partner | Trade flow | Indicator | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
| 3002. Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc | Germany | Netherlands | Imports | Value (US$) | 4,014,411,838.00 | 5,012,343,752.20 | 6,275,290,892.24 | 6,472,708,004.32 | 5,971,362,627.35 | 7,403,172,215.09 | 7,203,182,520.27 | 4,710,579,402.46 | 5,272,486,439.56 | 5,137,929,176.79 | 5,670,317,290.94 | 5,066,665,048.86 |
| Value Growth, YoY (%) | -3.91 | 24.85 | 25.19 | 3.14 | -7.74 | 23.97 | -2.70 | -34.60 | 11.92 | -2.55 | 10.36 | -10.64 |
The value of imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Germany from Netherlands totalled $ 5.06 billion in 2023. Sales of commodity group 3002 to Germany from Netherlands declined by 10.6% compared to 2022.imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" decreased by $ 603 million (the value of sales of commodity group 3002 to Germany from Netherlands was equal to $5.67 billion in 2022)
Imports of commodity group 3002 amounted to 4.79% of total merchandise imports to Germany from Netherlands (in 2023, total imports to Germany from Netherlands were $ 105 billion). The share of commodity group 3002 in total imports to Germany from Netherlands decreased by 0.208 p.p. compared to 2022 (it was 4.99% in 2022 and cumulative imports to Germany from Netherlands were equal to $ 113 billion).
Imports of commodity group 3002 accounted for 59% of total imports of group "" to Germany from Netherlands in 2023 (in 2023, the value of imports of commodity group to Germany from Netherlands was $8.48 billion). The share of purchases of commodity group 3002 in total imports of commodity group to Germany from Netherlands went down by 2.91 p.p. compared to 2022 (it was 62% in 2022, and imports of commodity group to Germany from Netherlands accounted for $9.04 billion).
The share of Netherlands in total imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Germany amounted to 13.8 percent (5.06 billion USD) in 2023 of 36 billion USD - the value of total merchandise imports of commodity group 3002 to Germany in 2023. The share of Netherlands in imports of commodity group 3002 "Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc" to Germany increased by 0.436 p.p. compared to 2022 (it was 13.4 percent in 2022, and total imports of commodity group 3002 to Germany were equal to 42 billion USD).